Can a video chat program ease the burden of chronic GVHD?

NCT ID NCT04479995

First seen Jun 27, 2026 ยท Last updated Jun 27, 2026

Summary

This study tests a telehealth program called Horizons for adults who have had a stem cell transplant and developed moderate to severe chronic graft-versus-host disease (GVHD). The program uses video sessions and questionnaires to help patients cope and follow their treatment plan. Researchers will compare it to standard care plus a booklet, aiming to see if the program is feasible and improves quality of life.

What this could mean

Our plain-language read of the trial. This is informational only โ€” not medical advice or a prediction.

Active substance
Horizons Program (telehealth counseling sessions)
What this could lead to
If it works, this could provide a practical way to help GVHD patients feel better and stick with their treatment.
What could go wrong
This is a small, early feasibility study (80 people) testing a behavioral program, not a new drug. It may not show clear benefits or work for everyone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC GRAFT VERSUS HOST DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Massachusetts General Hospital Cancer Center

    Boston, Massachusetts, 02114, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.